PSMA PET has become central to prostate cancer imaging as advanced disease incidence rises and prostate-specific membrane ...

A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators has shown that a newer technique for collecting prostate biopsy samples reduced the risk of ...

Earlier this week, researchers presented data from the OPTIMUM (Optimization of Prostate Biopsy – Micro-Ultrasound Versus MRI) trial at the European Association of Urology Congress in Madrid, Spain.

Scientists at the Karolinska Institute in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnosis and thereby improve prostate cancer screening. Now, the same team ...

A new imaging approach developed by researchers at Heriot-Watt University has shown "extremely encouraging" results in early-stage clinical trials on prostate cancer at the Western General Hospital in ...

Prostate-specific membrane antigen, or PSMA, -targeted PET imaging for prostate cancer has been a breakthrough diagnosis tool in locating prostate cancer tumors for more precise treatment. The new ...

In 2013, a prostate-specific antigen (PSA) blood test revealed that Richard LaFrate's levels had jumped. Previously in a normal range, LaFrate's PSA was now above 6 ng/mL, indicating an elevated ...

A new, pioneering procedure was used to treat a record number of prostate patients in a day. Frimley Health NHS Foundation trust were able to break their record thanks to the use of a robot-assisted ...

A multi-institutional clinical trial showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches. A ...